2024 U.S. Hospital Virology and Bacteriology Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Technologies Instrumentation and Opportunities

This new report from contains 997 pages and 87 tables.

The report is available by section, and can be customized to specific information needs and budget.

The report presents a comprehensive analysis of the US hospital infectious disease testing market, including: 

• Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. ;

• Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms. ;

• Volume and sales forecasts for 80 infectious disease tests performed in US hospital laboratories. ;

• Instrumentation technologies and feature comparison of leading analyzers. ;

• Sales and market shares of leading suppliers by test. ;

• Emerging diagnostic technologies and their potential market applications. ;

• Product development opportunities. ;

• Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

  Contains 997 pages and 87 tables

  
  
  
  TABLE OF CONTENTS
  Introduction
  Worldwide Market and Technology Overview
  A. Major Infectious Disease Tests
  1. AIDS
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  2. Adenovirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  d. Adeno-Associated Viruses(AAV)
  3. Aeromonas
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  4. Anthrax/Bacillus Anthracis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  5. Arboviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  6. Babesiosis
  a. Background
  7. Bacillary Epithelioid Angiomatosis (BEA)
  And Other Bartonella (Rochalimaea)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  8. Blastocystis Hominis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  
  9. Brucella
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  10. Campylobacter
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  11. Candida
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  12. Chagas Disease
  a. Background
  13. Chancroid
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  14. Chlamydia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  15. Clostridium Difficile
  a. Background
  b. Diagnostic Tests
  c. Drugs and Vaccines
  16. Coronaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  17. Coxsackieviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  18. Creutzfeldt-Jakobs Disease
  a. Background
  b. Diagnostic Tests
  c. Vaccines
  
  19. Cryptosporidium Parvum
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  20. Cyclospora Cayetanensis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  21. Cytomegalovirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  22. Ebola Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  23. E. Coli
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  24. EchoVirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  25. Encephalitis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  26. Enteroviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  27. Epstein-Barr Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  28. Giardia Lamblia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  
  29. Gonorrhea
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  30. Granuloma Inguinale
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  31. Hantavirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  32. Helicobacter Pylori
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  33. Hepatitis
  a. Background
  b. Hepatitis A
  c. Hepatitis B
  d. Hepatitis C
  e. Vaccines and Drugs
  34. Herpes Simplex Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  35. Human Herpes Virus-6 (HHV-6)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  36. Influenza Viruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  37. Legionella
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  
  38. Lyme Disease
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  39. Lymphogranuloma Venereum (LGV)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  40. Malaria
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  41. Measles (Rubeola)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  42. Meningitis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  43. Microsporidium
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  44. Mononucleosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  45. Mumps
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  46. Mycoplasma
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  47. Papillomaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  
  48. Parvovirus B19
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  49. Pneumonia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  50. Polyomaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  51. Pseudomonas Aeruginosa
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  52. Rabies
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  53. Respiratory Syncytial Virus (RSV)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  54. RhinoViruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  55. RotaVirus (REOVIRUS)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  56. Rubella(MEASLES)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  57. Salmonellosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  
  58. Septicemia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  59. Shigellosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  60. Staphylococcus Aureus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  61. Streptococci
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  62. Syphilis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  63. Toxoplasmosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  64. Trichomonas Vaginalis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  65. Tuberculosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  66. Vibrio
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  67. West Nile Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  
  68. Yersina
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  B. Instrumentation Review of Leading Analyzers Marketed
  by Abbott, Beckman Coulter/Danaher, BioMerieux,
  Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
  Wallac and Other Suppliers
  C. Emerging Diagnostic Technologies
  1. Molecular Diagnostics
  2. Monoclonal Antibodies
  3. Immunoassays
  4. Differential Light Scattering
  5. Information Technology
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. Diagnostic Imaging
  11. Gel Microdroplets
  12. Other
  U.S.A.
  A. Executive Summary
  B. Business Environment
  1. Health Care Expenditures
  2. Cost Consciousness
  3. Reimbursement
  4. Industry Consolidation
  5. Managed Care
  a. HMO
  b. PPO
  6. Hospitals
  7. Admissions
  8. Length of Stay
  9. Industry Diversification
  10. Physician Demographics
  11. Population Aging
  a. Chronic Illness
  b. Disease Incidence
  
  c. Susceptibility to Iatrogenesis
  d. Multiple Illness Cases
  12. Laboratory Regulations
  13. FDA Reform
  C. Market Structure
  1. Centralized Testing
  a. Hospitals
  b. Commercial/Private Laboratories
  c. Blood Banks
  1) Community and Regional Centers
  2) Plasma Fractionation Centers
  2. Decentralized Testing
  a. Physician Offices/Group Practices
  b. Point of Care Testing
  c. Other Decentralized Testing Locations
  D. Market Size, Growth and Major Suppliers
  Major Product Development Opportunities
  A. Instrumentation
  B. Reagent Kits and Test Systems/Panels
  C. Computers, Software and Automation
  D. Auxiliary Products
  Design Criteria for Decentralized Testing Products
  Alternative Market Penetration Strategies
  A. Internal Development
  B. Collaborative Arrangements
  C. University Contracts
  D. Distribution Strategies for Decentralized
  Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation
  
  Potential Market Entry Barriers and Risks
  A. Market Maturity
  B. Cost Containment
  C. Competition
  D. Technological Edge and Limitations
  E. Patent Protection
  F. Regulatory Constraints
  G. Decentralized Testing Market Challenges
  Competitive Assessments
  - Abbott
  - Affymetrix
  - Beckman Coulter/Danaher
  - Becton Dickinson
  - bioMerieux
  - Bio-Rad
  - Cepheid
  - Diamedix
  - DiaSorin
  - Eiken Chemical
  - Elitech Group
  - Enzo Biochem
  - Fujirebio
  - Grifols
  - GSK Biologicals
  - Hologic
  - Leica Biosystems
  - Lonza
  - Ortho-Clinical Diagnostics
  - PerkinElmer
  - Qiagen
  - Roche
  - Scienion
  - Sequenom
  - SeraCare
  - Siemens Healthineers
  - Takara Bio
  - Thermo Fisher
  - Wako
  
  

  List Of Tables

  Major Companies Developing or Marketing AIDS Tests
  Major Companies Developing or Marketing Adenovirus
  Tests
  Major Companies Developing or Marketing Bartonella
  Tests
  Major Companies Developing or Marketing
  Campylobacter Tests
  Major Companies Developing or Marketing Candida
  Tests
  Major Companies Developing or Marketing Chlamydia
  Tests
  Major Companies Developing or Marketing Clostridium
  Tests
  Major Companies Developing or Marketing Coronavirus
  Tests
  Major Companies Developing or Marketing Cryptosporidium
  Tests
  Major Companies Developing or Marketing CMV Tests
  Major Companies Developing or Marketing Echovirus
  Tests
  Major Companies Developing or Marketing Enterovirus
  Tests
  Major Companies Developing or Marketing EBV Tests
  
  Major Companies Developing or Marketing Giardia
  Tests
  Major Companies Developing or Marketing Gonorrhea
  Tests
  Major Companies Developing or Marketing Hantavirus
  Tests
  Major Companies Developing or Marketing Helicobacter
  Pylori Tests
  Major Companies Developing or Marketing Hepatitis
  Tests
  Major Companies Developing or Marketing Herpes
  Tests
  Major Companies Developing or Marketing Influenza
  Tests
  Major Companies Developing or Marketing Legionella
  Tests
  Major Companies Developing or Marketing Lyme Disease
  Tests
  Major Companies Developing or Marketing Lymphogranuloma
  Tests
  Major Companies Developing or Marketing Malaria
  Tests
  Major Companies Developing or Marketing Measles
  Tests
  Major Companies Developing or Marketing Meningitis
  Tests
  
  Major Companies Developing or Marketing Microsporidium
  Tests
  Major Companies Developing or Marketing
  Mononucleosis Tests
  Major Companies Developing or Marketing Mumps Tests
  Major Companies Developing or Marketing Mycoplasma
  Tests
  Major Companies Developing or Marketing Papilloma
  Virus Tests
  Major Companies Developing or Marketing Parvovirus
  Tests
  Major Companies Developing or Marketing Pneumonia
  Tests
  Major Companies Developing or Marketing RSV Tests
  Major Companies Developing or Marketing Rotavirus
  Tests
  Major Companies Developing or Marketing Rubella
  Tests
  Major Companies Developing or Marketing Salmonella
  Tests
  Major Companies Developing or Marketing Septicemia
  Tests
  Major Companies Developing or Marketing Shigella
  Tests
  Major Companies Developing or Marketing Staphylococci
  Tests
  
  Major Companies Developing or Marketing
  Streptococci Tests
  Major Companies Developing or Marketing Syphilis
  Tests
  Major Companies Developing or Marketing Toxoplasmosis
  Tests
  Major Companies Developing or Marketing Trichomonas
  Tests
  Major Companies Developing or Marketing Tuberculosis
  Tests
  Major Companies Developing or Marketing West Nile
  Tests
  Major Companies Developing or Marketing Yersinia Tests
  U.S.A. Summary Table
  All Infectious Diseases Test Volume and Diagnostics
  Sales Forecast
  U.S.A.
  Hospital Laboratories Performing Infectious Disease
  Tests by Bed Size
  U.S.A.
  Hospital Laboratories Infectious Disease Test Volume Forecast
  U.S.A.
  Hospital Laboratories Infectious Disease Diagnostics
  Market Forecast
  U.S.A.
  AIDS Testing Market Diagnostics Sales
  by Major Supplier
  
  U.S.A.
  Adenovirus Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Campylobacter Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Candida Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Chancroid Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Chlamydia Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  CMV Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Cryptosporidium Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Echovirus Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Enterovirus Testing Market Diagnostics Sales
  by Major Supplier
  
  U.S.A.
  EBV Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Giardia Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Gonorrhea Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Helicobacter Pylori Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Hepatitis Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Hepatitis C Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Herpes Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Influenza Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Legionella Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Lyme Disease Testing Market Diagnostics Sales
  by Major Supplier
  
  U.S.A.
  Measles Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Meningitis Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Mononucleosis Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Mumps Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Mycoplasma Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Pneumonia Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Rabies Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  RSV Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Rotavirus Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Rubella Testing Market Diagnostics Sales
  by Major Supplier
  
  U.S.A.
  Salmonella Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Septicemia Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Shigella Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Streptococci Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Syphilis Testing Market Diagnostics Sales
  by Major Supplier
  U.S.A.
  Toxoplasmosis Testing Market Diagnostics Sales
  by Major Supplier
  
  
  RELATED REPORTS
  2024 U.K. Hospital Virology and Bacteriology Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Technologies Instrumentation and Opportunities

  2024 U.K. Hospital Virology and Bacteriology Testing Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and OpportunitiesThis new report from contains 886 pages and 67

  USD 3500 View Report

  2024 Spain Hospital Virology and Bacteriology Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Technologies Instrumentation and Opportunities

  2024 Spain Hospital Virology and Bacteriology Testing Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities This new report from contains 880 pages and

  USD 3500 View Report

  2024 U.S. Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations

  2024 U.S. Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The

  USD 2500 View Report

  2024 U.S. Drugs of Abuse POC Decentralized Testing Market

  2024 U.S. Drugs of Abuse POC/Decentralized Testing Market: Country Supplier Shares, Test Volume and Sales Segment ForecastsThis new 165-page report from contains 14 tables, and provides a comprehensive analysis

  USD 2500 View Report
  SAMPLE REQUEST

  Fill The Form For Sample Request

  Full Name*

  Business Email *

  E-mail

  Country *

  Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

  Contact No *

  Alternate No

  Note : * Kindly provide us with your company id and get the sample reports at the earliest.
  REVIEWS

  There is no Reviews available